Janus Pharmaceuticals, Inc.
Records under this name other than patents Janus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Janus Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,358,944 | Methods and compositions for treating generalized anxiety disorder Formerly held Term ended Term ended Aug 23, 2020 · USPTO record | Term ended | Term ended Aug 23, 2020 | USPTO record |
| US 6,395,788 | Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine Term ended Term ended Aug 11, 2020 · USPTO record | Term ended | Term ended Aug 11, 2020 | USPTO record |
| US 6,080,736 | Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam Formerly held Term ended Term ended Oct 27, 2019 · USPTO record | Term ended | Term ended Oct 27, 2019 | USPTO record |